Heparin Cofactor II (SERPIND1) Rabbit Polyclonal Antibody
Specifications
| Product Data | |
| Application | IF, IHC |
|---|---|
| Recommended Dilution | IHC: 1:50~1:100, IF: 1:100~1:500, ELISA: 1:5000 |
| Reactivity | Human, Mouse, Rat |
| Antibody Host | Rabbit |
| Isotype | IgG |
| Clonality | Polyclonal |
| Immunogen | The antiserum was produced against synthesized peptide derived from internal of human Heparin Cofactor II. |
| Buffer | Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
| Concentration | lot specific |
| Purification | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Conjugation | Unconjugated |
| Storage | Store at -20°C as received. |
| Stability | Stable for 12 months from date of receipt. |
| Shipping | Blue Ice |
| Gene Name | serpin family D member 1 |
| Database Link | |
| Synonyms | D22S673; HC2; HCF2; HCII; HLS2; LS2; THPH10 |
| Note | Heparin Cofactor II antibody detects endogenous levels of total Heparin Cofactor II protein. |
| Reference Data | |
| Protein Categories | Cardiovascular diseases, Secreated Proteins |
| Protein Families | Druggable Genome |
| Protein Pathways | Complement and coagulation cascades |
Reviews
Documents
| Product Manuals |
| FAQs |
| SDS |
Citations
The construction and validation of integrated immune and metabolic gene signatures for clinical prognostic model of lung squamous cell carcinoma
Xue, Li, Han et al
Research Square (2024)
Xue, Li, Han et al
Research Square (2024)
Snippet: 3 IMMUNOHISTOCHEMISTRY (IHC) IHC was performed on paraffin-embedded LUSC specimens from 42 patients who met the inclusion and exclusion criteria. Four representative indicators—SERPIND1 (TA313999, OriGene, USA), LBP (HPA001508, ATLAS ANTIBODIES, Sweden), TSLP (GTX85060, GeneTex, USA), and MIOX (AB154639-1001, Abcam, UK)—were selected to verify the difference in expression between the tumours
Development and external validation of a composite immune-clinical prognostic model associated with EGFR mutation in East-Asian patients with lung adenocarcinoma
Liu, Zheng, Wang et al
Ther Adv Med Oncol (2021) 13, 17588359211006949 DOI: 10.1177/17588359211006949
Liu, Zheng, Wang et al
Ther Adv Med Oncol (2021) 13, 17588359211006949 DOI: 10.1177/17588359211006949
Cited by 8
AI Summary: OriGene contributed to this study by providing the anti-human ANGPT4 rabbit recombinant polyclonal antibody (TA350852), which was used for immunohistochemical assessment of ANGPT4 protein expression as part of validating the prognostic model in lung adenocarcinoma patients.
Snippet: of the selected 10 EIGs in the CICAMS cohort. Expression of 10 genes were assessed with IHC using an angiopoietin 4 (ANGPT4) assay (anti-human ANGPT4 rabbit recombinant polyclonal antibody, TA350852;OriGene, USA), a brain-derived neurotrophic factor (BDNF) assay (anti-human BDNF rabbit recombinant monoclonal antibody, ab108319;Abcam, USA), a fatty acid binding protein 7 (FABP7) assay (anti-human
Showing 1-2 of 2 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen
complexities in the preparation of your product. International customers may expect an additional 1-2 weeks
in shipping.
Related Products
- Price:
- Actual Price:
Welcome to OriGene AI!
I'm your AI-powered guide to everything OriGene.
Ask me anything:
- Product specs
- Ordering help
- Technical questions
- How to find exactly what your experiment needs
Prefer a live agent? Connect with us by clicking the green chat icon, as seen in the image below or email our team at custsupport@origene.com.
